Seminars in Nuclear Medicine
Volume 29, Issue 2 , Pages 160-174 , April 1999

Consensus on renal cortical scintigraphy in children with urinary tract infection

  • A. Piepsz

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • Corresponding Author InformationAddress reprint requests to Chairman: A. Piepsz, AZ VUB; Department of Nuclear Medicine, Laarbeeklaan 101, B-1090 Brussels, Belgium.
    • ,
  • M.D. Blaufox

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • I. Gordon

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • G. Granerus

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • M. Majd

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • P. O'Reilly

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • A.R. Rosenberg

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • M.A. Rossleigh

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden
    • ,
  • R. Sixt

      Affiliations

    • AZ VUB Department of Nuclear Medicine, Brussels, Belgium
    • Albert Einstein College of Medicine, Department of Nuclear Medicine NY USA
    • Hospital for Sick Children, London, UK
    • University Hospital, Department of Clinical Physiology, Linköping, Sweden
    • Children's National Medical Center, Department of Nuclear Medicine, Washington, DC USA
    • Stepping Hill Hospital, Department of Urology, Stockport, UK
    • Sydney Children's Hospital, Department of Nephrology, Sydney, Australia
    • Prince of Wales Hospital, Department of Nuclear Medicine, Sydney, Australia
    • East Hospital, Department of Pediatric Clinical Physiology, Gothenburg, Sweden

References 

  1. Mc Afee JG, Wagner HN. Visualisation of renal parenchyma: scintigram with 203 Hg neohydrin. Radiology. 1960;75:820–821
  2. Raynaud C, Jacquot C, Freeman LM. Measuring renal uptake of HgC12-197 by gamma camera. Radiology. 1974;110:413–417
  3. Taylor A, Davis G, Halpern S. Tc-99m penicillamine. A renal cortical scanning agent. J Urol. 1977;117:418–420
  4. de Kievit W. Technetium radiopharmaceuticals: chemical characterization and tissue distribution of Tc-Glucoheptonate using Tc-99m and carrier Tc-99. J Nucl Med. 1981;22:703–709
  5. Traisman ES, Conway JJ, Traisman HS, et al. The localization of urinary tract infection with Tc-99m glucoheptonate scintigraphy. Pediatr Radiol. 1986;16:403–406
  6. Sty JR, Wells RG, Starshak RJ, et al. Imaging in acute renal infection in children. AJR. 1987;148:403–406
  7. Sreenarasimhaiah V, Alon US. Uroradiological evaluation of children with urinary tract infection: are both ultrasonography and renal cortical scintigraphy necessary?. J Pediatr. 1995;127:373–377
  8. Lin TH, Khentigan A, Winchell HS. A Tc-99m chelate substitute for organomercurial renal agents. J Nucl Med. 1974;15:34–35
  9. Enlander D, Weber P, Dos Remedios LV. Renal cortical imaging in 35 patients, superior quality with Tc-99m DMSA. J Nucl Med. 1974;15:743–749
  10. Evans K, Lythgoe MF, Anderson PJ, et al. Biokinetic behavior of Tc-99m DMSA in children. J Nucl Med. 1996;37:1331–1336
  11. Moretti JL, Rapin JR, Saccavini JC, et al. 2, 3 dimercaptosuccinic acid chelates—2 renal localization. Int J Nucl Med Biol. 1984;11:275–279
  12. Peters AM, Jones DH, Evans K, et al. Two routes for Tc-99m DMSA uptake into the renal cortical tubular cell. Eur J Nucl Med. 1988;14:555–561
  13. De Lange MJ, Piers DA, Kosterinck JGW, et al. Renal handling of Tc-99m DMSA: evidence for glomerular filtration and peritubuluar uptake. J Nucl Med. 1989;30:1219–1223
  14. Müller Suur R, Gutsche HU. No evidence for tubular reabsorption of DMSA. Eur J Nucl Med. 1994;21:744
  15. Quinn RJ, Elder GJ. Poor technetium-99m DMSA renal uptake caused by tubulointerstitial renal disease. J Nucl Med. 1991;32:2273–2274
  16. Hecht H, Ohlsson J, Starck SA. Poor renal uptake of Tc-99m DMSA and near-normal Tc-99m MAG3 renogram in nephronophtisis. Pediatr Nephrol. 1996;10:167–170
  17. Handmaker H, Young BW, Lowenstein JM. Clinical experience with Tc-99m DMSA: a new renal-imaging agent. J Nucl Med. 1975;16:28–32
  18. Handmaker H. Nuclear renal imaging in acute pyelonephritis. Semin Nucl Med. 1982;12:246–253
  19. Piepsz A, Ham HR, Roland JH, et al. Tc-99m DMSA imaging and the obstructed kidney. Clin Nucl Med. 1986;11:389–391
  20. De Maeyer P, Simons M, Oosterlinck W, et al. A clinical study of Tc-99m DMSA uptake in obstructed kidneys: comparison with the creatinine clearance. J Urol. 1982;128:8–9
  21. Morales JO. Space-occupying lesions of the kidney. In: Freeman LM, Blaufox MD editor. Radionuclide studies of the genitourinary system. New York, NY: Grune and Stratton; 1974;p. 133–149
  22. Wujanto R, Testa HJ, Shields RA, et al. Assessment of renal function and scarring: is a DMSA scan always necessary?. In: Bischof-Delalye A, Blaufox MD editor. Radionuclides in nephrology. Basel: Karger; 1987;p. 250–255
  23. Gordon I, Anderson PJ, Lythgoe M, et al. Can Tc-99m Mercaptoacetyltriglycine replace Tc-99m DMSA in the exclusion of a focal renal defect?. J Nucl Med. 1992;33:2090–2093
  24. Piepsz A, Pintelon H, Verboven M, et al. Replacing Tc-99m DMSA for renal imaging?. Nucl Med Comm. 1992;13:494–496
  25. Yardi ÖF, Kabasakal L, Sönmesoglu K, et al. Comparison of Tc-99m DMSA and cortical phase summed images of Tc-99m EC in evaluation of split renal function and renal cortical diseases (abstract). Eur J Nucl Med. 1997;24:911
  26. Smith T, Evans K, Lythgoe MF, et al. Radiation dosimetry of Tc-99m DMSA in children. J Nucl Med. 1996;37:1336–1342
  27. Smith T, Gordon I, Kelly JP. Comparison of radiation dose from intravenous urography and Tc-99m DMSA scintigraphy in children. Br J Radiol. 1998;71:314–319
  28. Piepsz A, Hahn K, Roca I, et al. A radiopharmaceutical schedule for imaging in paediatrics. Eur J Nucl Med. 1990;17:127–129
  29. Almén A, Mattsson S. The radiation dose to children from X-ray examinations of the pelvis and the urinary tract. Br J Radiol. 1995;68:604–613
  30. Vestergren E. Administered activity of Tc-99m DMSA for kidney scintigraphy in children. Nucl Med Commun. 1998;19:695–701
  31. Arnold AJ, Brownless SM, Carty HM, et al. Detection of renal scarring by DMSA scanning: an experimental study. J Pediatr Surg. 1990;25:391–393
  32. Merrick MV, Uttley WS, Wild SR. The detection of pyelonephritic scarring in children by radioisotopic imaging. Br J Radiol. 1980;53:544–556
  33. Bingham JB, Maisey MN. An evaluation of the use of Tc99m DMSA as a static renal imaging agent. Br J Radiol. 1978;51:599–603
  34. Bjorgvinsson E, Majd M, Eggli KD. Diagnosis of acute pyelonephritis in children: comparison of sonography and Tc-99m DMSA scintigraph. Am J Roentgenol. 1991;157:539–543
  35. Melis K, Vandevivere J, Hoskens C, et al. Involvement of the renal parenchyma in acute urinary tract infection: the contribution of Tc-99m DMSA scan. Eur J Pediatr. 1992;151:536–539
  36. Jakobsson B, Nolstedt L, Svensson L, et al. Tc-99m DMSA scan in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings. Pediatr Nephrol. 1992;6:328–334
  37. Verber IG, Meller ST. Development of renal scars after acute nephronia in childhood: a study of sequential DMSA scans. In: Blaufox MD, Hollenberg NK, Raynaud C editor. Radionuclides in nephrology. Basel: Karger; 1990;p. 142–146
  38. Tappin DM, Murphy AV, Mocan H, et al. A prospective study of children with first acute symptomatic E. coli urinary tract infection. Early Tc-99m DMSA scan appearances. Acta Paediatr Scand. 1989;78:923–929
  39. Guermazi F, Lenoir P, Verboven M, et al. Apport de la scintigraphie à l'acide dimercaptosuccinique marqué au technétium 99m dans le diagnostic et le suivi des infections urinaires de l'enfant. Arch Fr Pediatr. 1993;50:391–398
  40. Verboven M, Ingels M, Delree M, et al. Tc-99m DMSA scintigraphy in acute urinary tract infection in children. Pediatr Radiol. 1990;20:540–542
  41. Benador D, Benador N, Slosman D, et al. Are younger children at higher risk of renal sequelae after pyelonephritis?. Lancet. 1997;349:17–19
  42. Benador D, Benador N, Slosman DO, et al. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr. 1994;124:17–20
  43. Linné T, Fituri O, Escobar-Billing R, et al. Functional parameters and Tc-99m DMSA scan in acute pyelonephritis. Pediatr Nephrol. 1994;8:694–699
  44. Goldraich NP, Goldraich IH. Update on DMSA renal scanning in children with urinary tract infection. Pediatr Nephrol. 1995;9:221–226
  45. Rossleigh MA, Wilson MJ, Rosenberg AR, et al. DMSA studies in infants under one year of age. In: Blaufox MD, Hollenberg NK, Raynaud C editor. Radionuclides in nephrology. Basel: Karger; 1990;p. 166–169
  46. Farnsworth RH, Rossleigh MA, Leighton DM, et al. The detection of reflux nephropathy in infants by Tc-99m DMSA studies. J Urol. 1991;145:542–546
  47. Goldraich NP, Ramos OL, Goldraich IH. Urography versus DMSA scan in children with vesicoureteric reflux. Pediatr Nephrol. 1989;3:1–5
  48. Majd M, Rushton HG, Jantausch B, et al. Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli and acute pyelonephritis in children with febrile urinary tract infection. J Pediatr. 1991;119:578–585
  49. Rushton HG. Renal scarring following pyelonephritis. J Urol. 1992;147:1327–1332
  50. Piepsz A, Tammien-Möbius T, Reiners C, et al. Five-years study of medical or surgical treatment in children with severe vesico-ureteral reflux dimercaptosuccinic acid findings. Eur J Pediatr. 1998;157:753–758
  51. Piepsz A. Les radioisotopes en uronéphrologie pédiatrique. Quelles questions, quels apports, quels pièges?. Médecine Nucléaire. 1995;19:314–323
  52. Risdon RA, Godley ML, Parkhouse HF, et al. Renal pathology and the Tc-99m DMSA image during the evolution of early pyelonephritic scar: an experimental study. J Urol. 1994;151:767–773
  53. Wikstad T, Hannerz L, Karlsson A, et al. Tc-99m DMSA scintigraphy in the diagnosis of acute pyelonephritis in rats. Pediatr Nephrol. 1990;4:331–334
  54. Part 2 Rushton HG, Majd M, Chandra R, et al. Evaluation of Tc-99m DMSA renal scans in experimental acute pyelonephritis in piglets. J Urol. 1988;140:1169–1174
  55. Majd M, Rushton HG, Chandra R, et al. Tc-99m DMSA renal cortical scintigraphy to detect experimental acute pyelone-. J Nucl Med. 1996;37:1731–1734
  56. Rossleigh MA, Farnsworth RH, Leighton DM, et al. Technetium-99m Dimercaptosuccinic acid scintigraphy studies of renal cortical scarring and renal length. J Nucl Med. 1998;39:1280–1285
  57. Giblin JG, O'Connor KP, Fildes RD, et al. The diagnosis of acute pyelonephritis in the piglet using single photon emission computerized tomography DMSA scintigraphy: a pathological correlation. J Urol. 1993;150:759–762
  58. Gacinovic S, Buscombe J, Costa DC, et al. Inter-observer agreement in the reporting of Tc-99m DMSA renal studies. Nucl Med Commun. 1996;17:596–602
  59. (abstract) Jasic E, Beatovic S, Zagar I, et al. Interobserver agreement in the reporting of Tc-99m DMSA renal scintigraphy: multicentric study. Eur J Nucl Med. 1997;24:867
  60. Patel K, Charron M, Hoberman A, et al. Intr- and interobserver variability in interpretation of DMSA scans using a set of standardized criteria. Pediatr Radiol. 1993;23:506–509
  61. (abstract) Piepsz A, Clarke SEM, Mackenzie R, et al. A study of the interobserver variability in reporting on Tc-99m DMSA scintigraphy. Eur J Nucl Med. 1993;20:867
  62. Everaert H, Flamen P, Franken PR, et al. Tc-99m DMSA renal scintigraphy for acute pyelonephritis in adults planar and/or SPET imaging. Nucl Med Commun. 1996;17:884–889
  63. (abstract) De Sadeleer C, Tondeur M, Melis K, et al. Variability in reporting on Tc-99m DMSA planar scintigraphy. Nucl Med Commun. 1998;19:490
  64. (abstract) Melis K, De Sadeleer C, Tondeur M, et al. Factors influencing the variability in reporting on Tc-99m DMSA planar scintigraphy. Nucl Med Commun. 1998;19:490
  65. (abstract) Tondeur M, Melis K, DE Sadeleer C, et al. Interobserver reproducibility of the Tc-99m DMSA uptake ratio. Nucl Med Commun. 1998;19:490–491
  66. Fleming JS, Cosgriff P, Houston A, et al. UK audit of relative renal function assessment by DMSA scintigraphy. Nucl Med Commun. 1998;19:989–997
  67. Stokland E, Hellström M, Hansson S, et al. Reliability of ultrasonography in identification of reflux nephropathy in children. BMJ. 1994;309:235–239
  68. Mandell GA, Cooper JA, Majd M, et al. Procedure guidelines for pediatric sedation in nuclear medicine. J Nucl Med. 1997;38:1640–1643
  69. American Academy of Pediatrics, Committee on drugs . Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics. 1992;89:1110–1115
  70. Pintelon H, Jonckheere MH, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety?. Nucl Med Commun. 1994;15:664–666
  71. Pintelon H, Dejonckheere M, Piepsz A. Pediatric nuclear medicine: a practical approach. Q J Nucl Med. 1997;41:263–268
  72. Ljung B. The child in diagnostic nuclear medicine. Eur J Nucl Med. 1997;24:683–690
  73. Piepsz A. Recent advances in pediatric nuclear medicine. Semin Nucl Med. 1995;25:165–182
  74. Ciofetta G, Gordon I, Piepsz A. Clinical applications of nuclear medicine. Arch Dis Child. 1988;63:321–328
  75. Piepsz A, Gordon I, Hahn K. Paediatric nuclear medicine. Eur J Nucl Med. 1991;18:41–66
  76. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med. 1992;22:98–111
  77. Daly MJ, Milutinovic J, Rudd TG, et al. The normal Tc-99m DMSA renal image. Radiology. 1978;128:701–704
  78. O'Reilly PH, Pollard AJ. Abnormal renal mobility: radionuclide features and clinical relevance. In: Blaufox MD, Hollenberg NK, Raynaud C editor. Radionuclides in nephrology. Basel: Karger; 1990;p. 99–102
  79. Wallin L, Bajc M. Typical Tc-99m DMSA distribution patterns in acute pyelonephritis. Acta Paediatr. 1993;82:1061–1065
  80. Wallin L, Helin I, Bajc M. Kidney swelling findings on DMSA scintigraphy. Clin Nucl Med. 1997;22:292–299
  81. Müller-Suur R, Mesko L. Combination of Tc-99m MAG3 gamma camera renography and Tc-99m DMSA scans for evaluation of acute pyelonephritis in children. In: O'Reilly PH, Taylor A, Nally JV editor. Radionuclides in nephrology. Blue Bell, PA: Fields and Wood; 1994;p. 91–97
  82. Anderson PJ, Todd-Pokropek A, Orton MJ, et al. Can a functional image of MAG3 renal clearance replace DMSA in the diagnosis of a renal scar?. In: Taylor A, Nally JV, Thomsen H editor. Radionuclides in nephrology. Reston, VA: Society of Nuclear Medicine; 1997;p. 105–111
  83. Sfakianakis GN, Zilleruelo G, Cavagnaro F, et al. A prospective comparative DMSA and MAG3 study in acute pyelonephritis. In: Taylor A, Nally JV, Thomsen H editor. Radionuclides in nephrology. Reston, VA: Society of Nuclear Medicine; 1997;p. 182–184
  84. Mouratidis B, Ash JM, Gilday DL. Comparison of planar and SPECT Tc-99m DMSA scintigraphy for the detection of renal cortical defects in children. Nucl Med Commun. 1993;14:82–86
  85. Mandell GA, Eggli DF, Gilday DL, et al. Procedure guideline for renal cortical scintigraphy in children. J Nucl Med. 1987;38:1644–1646
  86. Verber IG, Strudley MR, Meller ST. Tc-99m DMSA scan as first investigation of urinary tract infection. Arch Dis Child. 1988;63:1320–1325
  87. Piepsz A, Tamminen-Möbius T. Correlation between scintigraphic lesions and renal scarring in intravenous urogram in children with normal renal uptake of DMSA and evaluation of normal kidney findings of DMSA scan. In: Blaufox MD, Hollenberg NK, Raynaud C editor. Radionuclides in nephrology. Basel: Karger; 1990;p. 147–155
  88. Eggli DF, Tulchinsky M. Scintigraphic evaluation of pediatric urinary tract infection. Semin Nucl Med. 1993;23:199–218
  89. Verber IG, Meller ST. Serial Tc-99m DMSA scans after urinary infection presenting before the age of 5 years. Arch Dis Child. 1989;64:1533–1537
  90. De Sadeleer C, De Boe V, Keuppens F, et al. Can the outcome of renal abnormalities be predicted on the basis of the initial Tc-99m DMSA scintigraphy?. Eur J Nucl Med. 1993;20:867
  91. Jakobsson B. Importance of timing when using Tc-99m DMSA scan in urinary tract infection. In: Taylor A, Nally JV, Thomsen H editor. Radionuclides in nephrology. Reston, VA: Society of Nuclear Medicine; 1997;p. 185–189
  92. Rosenberg AR, Rossleigh MA, Brydon MP, et al. Evaluation of acute urinary tract infection in children by DMSA scintigraphy: a prospective study. J Urol. 1992;148:1746–1749
  93. Bagni B, Orsolon P, Fattori A, et al. Renal SPECT with Tc-99m DMSA in children with upper urinary tract infections using a triple headed gamma camera. Clin Nucl Med. 1997;22:838–843
  94. Yen TC, Chen WP, Chang SL, et al. Technetium-99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis. J Nucl Med. 1996;37:1349–1353
  95. Applegate KE, Connolly LP, Davis RT, et al. A prospective comparison of high-resolution planar, pinhole, and tripledetector SPECT for the detection of renal cortical defects. Clin Nucl Med. 1997;22:673–678
  96. Majd M, Rushton HG, Chandra R, et al. 99m Tc-DMSA renal cortical scintigraphy to detect experimental acute pyelonephritis in piglets: comparison of planar (pinhole) and SPECT imaging. J Nucl Med. 1996;37:1731–1734
  97. Rossleigh MA. The interrenicular septum. A normal anatomical variant seen on DMSA SPECT. Clin Nucl Med. 1994;19:953–955
  98. De Sadeleer C, Bossuyt A, Goes E, et al. Renal technetium-99m-DMSA SPECT in normal volunteers. J Nucl Med. 1996;37:1346–1349
  99. Hambye AS, Merlo P, Hermans J, et al. Kidney depth measured by using Tc-99m DMSA. Comparison with CAT scan: review of 50 measurements. Nucl Med Commun. 1992;13:488–493
  100. Fleming JS. A technique for the absolute measurement of activity using a gamma camera and computer. Phys Med Biol. 1979;24:176–180
  101. Merrick MV. Single kidney function. In: Essentials of nuclear medicine. Berlin: Springer-Verlag; 1998;p. 91–94
  102. Lythgoe MF, Gordon I. Estimation and relevance of depth correction in paediatric renal studies. Eur J Nucl Med. 1998;25:115–119
  103. Stokland E, Hellström M, Jacobsson B, et al. Early Tc-99m DMSA scintigraphy in symptomatic first-time urinary tract infection. Acta Paediatr. 1996;85:430–436
  104. Stokland E, Hellström M, Jacobbson B, et al. Renal damage one year after first urinary tract infection: role of DMSA scintigraphy. J Pediatr. 1996;129:815–820
  105. Kullendorff CM, Wallin L. DMSA scintigraphy in renal duplex system. Eur J Pediatr Surg. 1993;3:83–86
  106. Blaufox MD. Procedures of choice in renal nuclear medicine. J Nucl Med. 1991;32:1301–1309
  107. Dick PT, Feldman W. Routine diagnostic imaging for childhood urinary tract infections: a systematic overview. J Pediatr. 1986;128:15–22
  108. Jakobsson B. The role of Tc-99m DMSA scan in urinary tract infection in children. In: O'Reilly PH, Taylor A, Nally JV editor. Radionuclides in nephrology. Blue Bell, PA: Fields and Wood; 1994;p. 91–97
  109. Smellie JM. The DMSA scan and intravenous urography in the detection of renal scarring. Editorial comment. Pediatr Nephrol. 1989;3:6–8
  110. Smellie JM, Rigden SPA. Pitfalls in the investigation of children with urinary tract infection. Arch Dis Child. 1995;72:251–258
  111. Smellie JM, Rigden SPA, Prescod NP. Urinary tract infection: a comparison of four methods of investigation. Arch Dis Child. 1995;72:247–250
  112. Bensman A. Conférence de consensus en thérapeutique anti-infectieux (16–18 Novembre 1990). Le traitement de la pyélonéphrite aiguë de l'enfant. Arch Fr Pediatr. 1991;48:229–232
  113. Stark H. Urinary tract infection in girls: the cost-effectiveness of currently recommended investigative routines. Pediatr Nephrol. 1997;11:174–177
  114. Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand. 1975;64:201–208
  115. Conway JJ, Cohn RA. Evolving role of nuclear medicine for the diagnosis and management of urinary tract infection. Editor's column. J Pediatr. 1994;124:87–90
  116. Redman JF, Seibert JJ. The role of excretory urography in the evaluation of girls with urinary tract infection. J Urol. 1984;132:953–955
  117. Merrick MV, Notghi A, Chalmers N, et al. Long term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: scarring. Arch Dis Child. 1995;72:393–396
  118. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child. 1994;70:111–115
  119. Vernon SJ, Coulthard MG, Lambert HJ, et al. New renal scarring in children who at age 3 and 4 years had had normal scans with DMSA: follow up study. BMJ. 1997;315:905–908
  120. Cornu C, Cochat P, Collet JP, et al. Survey of the attitudes to management of acute pyelonephritis in children. Pediatr Nephrol. 1994;8:275–277
  121. Jodal U. Treatment trials on children with acute pyelonephritis. Editorial comment. Pediatr Nephrol. 1994;8:278–279
  122. Hoberman A, Wald ER. Urinary tract infections in young febrile children. Pediatr Infect Dis J. 1997;16:11–17
  123. Sermet I, Vasmant D, Cohen R. Faut-il raccourcir le traitement parentéral de la pyélonéphrite aiguë de l'enfant?. Ann Pédiatr (Paris). 1998;45:35–42
  124. Piepsz A, Ham H. Investigations of girls with urinary tract infection (letter to the editor). Pediatr Nephrol. 1998;12:338–339
  125. Mandell Ga. Economic issue in pediatric nuclear medicine: cortical scanning of acute pyelonephritis. Q J Nucl Med. 1997;41:302–308

1 With the participation of the following experts: B. Bagni, Italy; M. Gelfand, USA; N. Goldraich, Brazil; D. Groshar, Israël; R. Howman-Giles, Australia; B. Jakobsson, Sweden; E. Jacsic, Yugoslavia; N. Karatzas, Greece; J. Le Cloirec, France: R. Mackenzie, UK; G. Mandell, USA; M.D. Mann, South Africa; K. Melis, Belgium; M.V. Merrick, UK; H. Nadel, Canada; C. Reiners, Germany; I. Roca, Spain; D.B. Schere, Argentina; G. Sfakianakis, USA; D.O. Slosman, Switzerland; S. Treves, USA; L. Wallin, Sweden.

PII: S0001-2998(99)80006-3

Seminars in Nuclear Medicine
Volume 29, Issue 2 , Pages 160-174 , April 1999

Article Tools